36 completed, 4 unknown, 2 active not recruiting, 1 enrolling by invitation. 18 Phase 4, 11 Phase 2, 11 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 18 | Completed 13, Active not recruiting 2, Unknown 2, Enrolling by invitation 1 |
| Phase 2 | 11 | Completed 10, Recruiting 1 |
| Phase 3 | 11 | Completed 10, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
Follow adacel: new trials by email Literature Review of adacel trials Research Report on adacel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ESCUDDO Long Term Follow Up Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Recombinant Human Papillomavirus Nonavalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Malignant Neoplasm | Phase 4 | Enrolling by invitation | National Cancer Institute (NCI) | 13700 | 2026-08-11 | 2026-09-22 |
| Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial Biopsy, Biospecimen Collection, Computed Tomography - Advanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma | Phase 2 | Recruiting | Mayo Clinic | 78 | 2024-11-12 | 2026-10-02 |
| Maternal Determinants of Infant Immunity to Pertussis Triaxis® (Pertussis-containing vaccine), Vaxelis® (Pertussis-containing vaccine) - Vaccination; Infection, Maternal-Fetal Relations | Phase 4 | Completed | Centre Hospitalier Universitaire Saint Pierre | 200 | 2023-09-12 | 2026-01-13 |
| Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination | Phase 2 | Completed | ABO Holdings, Inc. | 107 | 2023-05-05 | 2026-07-02 |
| Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women Adacel (Tdap) - dTap Vaccine | Phase 4 | Completed | Farzanah Laher | 511 | 2022-03-08 | 2026-05-15 |
| Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Questionnaire Administration, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Active not recruiting | National Cancer Institute (NCI) | 5000 | 2022-03-01 | 2026-10-22 |
| The Optimal Timing of Vaccination in Pregnancy Triaxis, Sanofi Pasteur - Pertussis/Whooping Cough | Unknown | Elke Leuridan, MD, PhD | 96 | 2021-07-01 | 2024-06-20 | |
| Tdap Vaccine Safety for Plasma Donors Adacel - Tetanus | Phase 2 / Phase 3 | Completed | GCAM Inc. | 110 | 2020-02-03 | 2022-12-06 |
| Optimising Protection for Pregnant Women and Infants With Maternal Vaccination Quadrivalent Influenza Vaccine, DTP Vaccine (Multiple Actives) - Obesity | Unknown | Women's and Children's Hospital, Australia | 73 | 2018-08-28 | 2024-01-31 | |
| 3-year Follow-up After a Single Dose Acellular Pertussis Vaccination Pertagen (aP BioNet), Boostagen (TDaP BioNet), Adacel - Pertussis | Completed | Mahidol University | 181 | 2018-06-26 | 2019-10-01 | |
| Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Questionnaire Administration, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Active not recruiting | National Cancer Institute (NCI) | 27945 | 2017-11-29 | 2025-09-04 |
| Adacel® Booster Vaccination for CMI Assay Development Adacel® - Pertussis | Phase 4 | Completed | Dalhousie University | 10 | 2017-07-12 | 2020-09-10 |
| 2-year Follow-up After a Single Dose Acellular Pertussis Vaccination Pertagen (aP BioNet), Boostagen (TdaP BioNet), Adacel - Pertussis | Completed | Mahidol University | 180 | 2017-06-20 | 2019-10-03 | |
| Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects CYD Dengue Vaccine, Tdap: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine adsorbed, Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed - Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | Terminated | Sanofi Pasteur, a Sanofi Company | 688 | 2016-12-19 | 2022-03-25 |
| Maternal Tdap Immunization in Guatemala Tdap, Td - Pertussis, Whooping Cough | Phase 2 | Completed | Emory University | 286 | 2016-07-01 | 2019-10-16 |
| Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Ibrutinib, Laboratory Biomarker Analysis - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Completed | Jennifer Woyach | 42 | 2016-01-12 | 2026-04-06 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine, Meningococcal (Groups A, C, Y and W135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed - Meningitis, Meningococcal Meningitis | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 1715 | 2014-07-22 | 2022-04-04 |
| Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed, Diphtheria and Tetanus toxoids adsorbed - Tetanus, Diphtheria | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 534 | 2014-03-01 | 2017-05-30 |
| Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China. Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap (ADACEL), DT vaccine (Diphtheria and Tetanus Combined Vaccine, Adsorbed), Td vaccine (Diphtheria and Tetanus Combined Vaccine for Adults and Adolescents, Adsorbed) - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1440 | 2013-11-01 | 2015-05-19 |
| Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap - Diphtheria, Tetanus | Phase 1 | Completed | Sanofi Pasteur, a Sanofi Company | 40 | 2013-08-01 | 2016-03-07 |
Showing 20 of 45. Sign in to see all of them.
Whooping Cough (32) · Tetanus (24) · Diphtheria (22) · Dengue (3) · Meningitis (3) · Meningococcal Infections (3) · Severe Dengue (3) · Papillomavirus Infections (2) · Infections (1) · Influenza, Human (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Meningitis, Meningococcal (1) · Obesity (1) · Poliomyelitis (1)
Sanofi Pasteur, a Sanofi Company (21) · National Cancer Institute (NCI) (3) · Sanofi (3) · GlaxoSmithKline (2) · Mahidol University (2) · ABO Holdings, Inc. (1) · Centre Hospitalier Universitaire Saint Pierre (1) · Dalhousie University (1) · Elke Leuridan, MD, PhD (1) · Emory University (1) · Farzanah Laher (1) · GCAM Inc. (1) · Hospital Universitario Dr. Jose E. Gonzalez (1) · Jennifer Woyach (1) · Mayo Clinic (1)
United States (16) · Canada (7) · Costa Rica (3) · Belgium (2) · China (2) · Japan (2) · Mexico (2) · Puerto Rico (2) · South Korea (2) · Thailand (2) · Australia (1) · Brazil (1) · Colombia (1) · Germany (1) · Guatemala (1)
Aimee R Kreimer (2) · Scott A Halperin, MD (2) · Adam Thaler, DO (1) · Aimee Kreimer (1) · Eva Netterlid (1) · Helen S Marshall, MBBS,MD,MPH (1) · Jennifer Woyach, MD (1) · Jose M Ramirez, MD; PhD (1) · Leif Gothefors, Prof. em. (1) · Matthew S. Block, MD, PhD (1) · Monique L MacFarlane Conrad, MSc (1)
PMID 32932330, PMID 41276263, PMID 16511379, PMID 20616762, PMID 21945698, PMID 22115634, PMID 24067553, PMID 24189367, PMID 25008903, PMID 25230939, PMID 26057135, PMID 27388557, PMID 29438562, PMID 29573876, PMID 30010773, PMID 31301919, PMID 31945015, PMID 32078808, PMID 32209248, PMID 33857679, PMID 34117198, PMID 34608724, PMID 34857420, PMID 37773052, PMID 38461048, PMID 41337735
2008 (1), 2019 (1)